Agustin Melian

Chief Medical Officer, Kalaris Therapeutics, Inc.

Companies

Forma Therapeutics Holdings, Inc.EVP, Research & Development Jul 12, 2022 to Oct 14, 2022¹
Kalaris Therapeutics, Inc.Chief Medical Officer Jul 30, 2020 to Oct 5, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kalaris Therapeutics, Inc. KLRS453,529 shares³$866.2K at $1.91Oct 4, 2021
Forma Therapeutics Holdings, Inc.0 shares⁴Oct 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 14, 2022U 79,000 shares of Forma Therapeutics Holdings, Inc.⁴
Jul 11, 2022Granted 79,000 shares of Forma Therapeutics Holdings, Inc.⁵
Oct 4, 2021Sold 333 shares at $26.02 of Kalaris Therapeutics, Inc.³
Oct 4, 2021Sold 2,967 shares at $25.41 of Kalaris Therapeutics, Inc.³
Oct 4, 2021Sold 4,711 shares at $24.23 of Kalaris Therapeutics, Inc.³
Oct 4, 2021Sold 10,678 shares at $23.29 of Kalaris Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARForma Therapeutics Holdings, Inc., EVP, Research & Development
2
SEC EDGARKalaris Therapeutics, Inc., Chief Medical Officer
3
SEC EDGARKalaris Therapeutics, Inc. shares after the filing of Oct 4, 2021
4
SEC EDGARForma Therapeutics Holdings, Inc. shares after the filing of Oct 14, 2022
5
SEC EDGARForm 4 filed Jul 12, 2022